Yongin-si, South Korea

Ho Kyun Han



Average Co-Inventor Count = 12.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ho Kyun Han: Innovator in Pharmaceutical Chemistry

Introduction

Ho Kyun Han is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various disorders. With a total of 2 patents to his name, Han's work is recognized for its potential impact on healthcare.

Latest Patents

Han's latest patents include innovative compounds aimed at addressing critical health issues. One of his patents focuses on arylpiperazine-containing imidazole 4-carboxamide derivatives. This invention provides a pharmaceutical composition that serves as an active ingredient for preventing or treating depressive disorders. Another significant patent involves orally bioavailable prodrugs of (+)-3-hydroxymorphinan, which are designed for the prevention or treatment of Parkinson's disease. These advancements highlight Han's commitment to improving therapeutic options for patients.

Career Highlights

Ho Kyun Han is currently associated with The Green Cross Corporation, where he continues to advance his research and development efforts. His work at this esteemed organization allows him to collaborate with other experts in the field and contribute to innovative healthcare solutions.

Collaborations

Han has worked alongside talented colleagues, including Jinhwa Lee and Min Ju Kim. Their collaborative efforts have fostered a productive environment for innovation and research.

Conclusion

Ho Kyun Han's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a key innovator in the field. His work not only enhances the understanding of complex disorders but also paves the way for new treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…